Home/Filings/4/0001628908-24-000044
4//SEC Filing

Tutewohl Steve 4

Accession 0001628908-24-000044

CIK 0001628908other

Filed

Apr 25, 8:00 PM ET

Accepted

Apr 26, 4:03 PM ET

Size

5.5 KB

Accession

0001628908-24-000044

Insider Transaction Report

Form 4
Period: 2023-07-01
Tutewohl Steve
Chief Operating Officer
Transactions
  • Award

    Class A Common Stock

    2023-07-01+9,000136,331 total
Footnotes (3)
  • [F1]This Form 4 is being filed late due to an administrative error.
  • [F2]Represents restricted stock units granted to Mr. Tutewohl pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. On July 31, 2023, Mr. Tutewohl's last day of employment with the company, 3,000 of these RSUs vested and the remaining 6,000 were forfeited, in accordance with the terms of Mr. Tutewohl's severance and change in control agreement. Mr. Tutewohl ceased to be an officer of the company on July 3, 2023.
  • [F3]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

Issuer

Evolent Health, Inc.

CIK 0001628908

Entity typeother

Related Parties

1
  • filerCIK 0001811845

Filing Metadata

Form type
4
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 4:03 PM ET
Size
5.5 KB